Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 3566-3572, May 15, 2008. doi: 10.1158/0008-5472.CAN-07-6639
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Kefas, B.
Right arrow Articles by Purow, B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kefas, B.
Right arrow Articles by Purow, B.

Priority Reports

microRNA-7 Inhibits the Epidermal Growth Factor Receptor and the Akt Pathway and Is Down-regulated in Glioblastoma

Benjamin Kefas1, Jakub Godlewski2, Laurey Comeau1, Yunqing Li1, Roger Abounader1, Michael Hawkinson1, Jeongwu Lee3, Howard Fine3, E. Antonio Chiocca2, Sean Lawler2 and Benjamin Purow1

1 Division of Neuro-Oncology, Neurology Department, University of Virginia Health System, Charlottesville, Virginia; 2 Dardinger Laboratory for Neuro-Oncology and Neurosciences, Department of Neurological Surgery, Ohio State University Medical Center, Columbus, Ohio; and 3 Neuro-Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland

Requests for reprints: Benjamin Purow, University of Virginia Neuro-Oncology Center, Box 800434, Hospital West Complex 6th Floor, Charlottesville, VA 22908. Phone: 434-924-5545; Fax: 434-243-6843; E-mail: bwp5g{at}virginia.edu.

Key Words: microRNA • EGFR • Akt • glioblastoma • microRNA-7

microRNAs are noncoding RNAs inhibiting expression of numerous target genes, and a few have been shown to act as oncogenes or tumor suppressors. We show that microRNA-7 (miR-7) is a potential tumor suppressor in glioblastoma targeting critical cancer pathways. miR-7 potently suppressed epidermal growth factor receptor expression, and furthermore it independently inhibited the Akt pathway via targeting upstream regulators. miR-7 expression was down-regulated in glioblastoma versus surrounding brain, with a mechanism involving impaired processing. Importantly, transfection with miR-7 decreased viability and invasiveness of primary glioblastoma lines. This study establishes miR-7 as a regulator of major cancer pathways and suggests that it has therapeutic potential for glioblastoma. [Cancer Res 2008;68(10):3566–71]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.